News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
441
Sources here
21
Companies here
7
Search results Stored financial headlines

Active search

441 matching headlines

Ticker or company: DOCMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Cielo Selects Amdocs to Bring Intelligent Connectivity to Its Entire Brazilian Payment Terminal Network

Cielo, a major Brazilian payment services provider, has partnered with Amdocs to modernize its nationwide payment terminal network. By adopting Amdocs Remote eSIM Manager, Cielo will transition from traditional SIM cards to an intelligent, software-defined connectivity model, ensuring continuous and optimized payment processing across …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Optimum launches redesigned billing platform with Amdocs By Investing.com

Optimum has partnered with Amdocs to launch a redesigned customer billing experience. The new digital platform uses visual insights and AI to provide clearer monthly bills, explain changes from previous statements, and reduce the need for customers to contact customer service for billing inquiries. …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PLDT Home Selects Amdocs to Modernize Core Business Platform, Advancing Cloud-Ready Transformation

Upgrade will boost business agility, streamline customer operations and establish a scalable foundation for future digital innovation JERSEY CITY, NJ / ACCESS Newswire / August 5, 2026 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sunrise Extends its Strategic Collaboration with Amdocs, Advancing its CRM Evolution with aOS

The Swiss telecommunications operator is to modernize and evolve its CRM with aOS, Amdocs's agentic operating system for telco, to help its frontline staff work more efficiently JERSEY CITY, NJ / ACCESS Newswire / August 5, 2026 / Amdocs (NASDAQ:DOX), a leading provider of …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lumen to Build Service Platform Across AWS, Azure and Google Cloud

Amdocs announced an expanded cloud collaboration with Lumen Technologies to modernize Lumen's enterprise service orchestration and order management platform on Amazon Web Services (AWS). This initiative builds on previous migrations to Google Cloud and Microsoft Azure, establishing a multi-cloud environment. Amdocs' aOS and AI-driven …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Healthpeak Properties (NYSE: DOC) details Janus Living IPO and Brookfield JV

Healthpeak Properties (NYSE: DOC) reported Q2 2026 revenues of $771.6 million and net income of $52.8 million. The company completed the Janus Living, Inc. IPO, raising $966 million, and a follow-on offering for $719 million, retaining a 73.6% stake. Healthpeak also formed a joint …

DOC main company
Sharemaestro market context Trend signal active 52 weeks +24.0% DOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sunrise Plans AI Analytics to Help Call Center Staff Work Faster

Amdocs announced that Swiss telecom operator Sunrise has extended its collaboration to modernize Sunrise's CRM environment using Amdocs' aOS, an agentic operating system for telcos. This initiative aims to integrate AI analytics and streamline workflows for customer service representatives, leading to faster issue resolution …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Liberty Latin America Announces 10-Year Strategic Engagement with Amdocs

Liberty Latin America has announced a 10-year strategic engagement with Amdocs to manage its end-to-end IT ecosystem. This partnership aims to transform Liberty Latin America's IT operations into an AI-driven model, accelerating innovation, enhancing customer experience, and achieving significant cost savings. Amdocs will collaborate …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amdocs Limited Reports Third Quarter Fiscal 2026 Results

Amdocs Limited reported solid Q3 fiscal 2026 results with revenue of $1.17 billion, up 2.7% year-over-year as reported, and reiterated its fiscal 2026 revenue growth outlook. The company announced a multi-year strategic engagement with Liberty Latin America to manage and transform its IT domain …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PRDO - 5/8/26 - Perdoceo Education Corporation

Perdoceo Education (PRDO) is currently trading at US$33.03, significantly undervalued by 64% compared to its intrinsic fair value of US$91.64, based on a discounted free cash flow model. The company exhibits strong financials with a 16.4% return on invested capital, 24.3% operating margin, and …

PRDO main company
Sharemaestro market context Price below Trend Line 52 weeks -2.2% · Next-week setup positive 58.4% PRDO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teladoc Health, Inc. (TDOC) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Teladoc Health, Inc. (TDOC) following the company's Q2 2026 financial results, which reported lower-than-expected revenue and a reduced full-year guidance. The investigation focuses on potential claims for investors who purchased Teladoc Health securities, especially …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Here's What Key Metrics Tell Us About Amdocs (DOX) Q3 Earnings

Amdocs (DOX) reported Q3 2026 revenue of $1.17 billion, a 2.7% year-over-year increase, and EPS of $1.84. While revenue slightly missed the Zacks Consensus Estimate, the company's EPS matched expectations. Key geographic revenue metrics showed North America with a modest increase, while Rest of …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Wall Street Bullish or Bearish on Healthpeak Properties Stock?

Healthpeak Properties Inc_ on screen in front of website By Timon With a market cap of $14.9 billion, Denver, Colorado-based Healthpeak Properties, Inc. (DOC) is a REIT in the United States that acquires, develops, manages, sells, and leases a diverse portfolio of healthcare real …

DOC main company
Sharemaestro market context Trend signal active 52 weeks +24.0% DOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tech headquarters for sale at a price few S.F. buildings have fetched since the pandemic

Pimco is listing the Docusign headquarters at 221 Main Street in San Francisco for sale at an asking price of $650 per square foot. This potential transaction could represent one of the highest values for an office building in the San Francisco market in …

DOCU main company
Sharemaestro market context Trend signal active 52 weeks -17.1% DOCU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amdocs (DOX) Could Be 31% Undervalued Following Q2 Earnings Focus

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Amdocs (DOX) is in focus as it prepares to report Q2 earnings this Wednesday after market close, with the market watching for the expected 2.7% …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vivo Selects Amdocs to Advance OSS Modernization with Upgrade to Amdocs CES2X

Vivo has renewed its strategic collaboration with Amdocs, upgrading its Customer Experience Suite (CES) to CES2X and aligning licensing capacity to support its growing customer base. This initiative modernizes Vivo's OSS environment, enhancing service activation, inventory, and provisioning capabilities, and establishing a foundation for …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Healthpeak Receives About $1.03B From Brookfield Outpatient Deal

Healthpeak Properties announced its Q2 2026 results, including FFO as Adjusted of $0.46 per share, and raised its full-year 2026 earnings guidance. The company generated $1.4 billion in proceeds from outpatient medical recapitalizations, seller financing loan repayments, and dispositions, notably closing a joint venture …

DOC main company
Sharemaestro market context Trend signal active 52 weeks +24.0% DOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc Health (NYSE: TDOC) director Mark Anquillare submits initial Form 3

Teladoc Health Inc. (NYSE: TDOC) director Mark V. Anquillare has filed an initial Form 3, indicating his beneficial ownership of securities as a director. The filing reports no equity transactions and includes a reference to a Power of Attorney. This Form 3 establishes Anquillare's …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Renewed Analyst Confidence Ahead of Earnings Will Impact Amdocs (DOX) Investors

Amdocs recently announced it would report quarterly earnings after the market close, with consensus expecting revenue growth compared with the same period last year, reversing a prior decline. Analysts have largely reaffirmed their estimates and highlighted Amdocs as a comparatively attractive value option versus …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amdocs VP Anjali Mahajan on women in tech, leadership, and navigating the AI shift

Anjali Mahajan, VP and Head of Engineering Services at Amdocs, discusses her 29-year career in tech, balancing motherhood with leadership, and fostering opportunities for women in the industry. She emphasizes the importance of connecting technology to business and preparing the next generation for an …

DOX main company
Sharemaestro market context New activity signal 52 weeks -32.6% DOX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Director Anquillare Mark V

This article reports a change in the beneficial ownership of securities for Mark V. Anquillare, a Director at Teladoc Health. The filing is a Statement of Changes in Beneficial Ownership, also known as a Form 4. This indicates that there has been a transaction …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DocuSign (NASDAQ: DOCU) director acquires 869 shares from RSUs

DocuSign director Rowan M. Trollope acquired 869 shares of common stock by exercising restricted stock units (RSUs) at $0.00 per share on August 2, 2026. Following this transaction, he directly holds 869 common shares and 9,569 restricted stock units. The RSUs vest in quarterly …

DOCU main company
Sharemaestro market context Trend signal active 52 weeks -17.1% DOCU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Healthpeak (DOC) Surpasses Q2 FFO and Revenue Estimates

Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.46 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to FFO of $0.46 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report …

DOC main company
Sharemaestro market context Trend signal active 52 weeks +24.0% DOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc Health

This article provides an overview of Teladoc Health (TDOC), a company specializing in telehealthcare services. It details the company's profile, including its founding, headquarters, CEO, and employee count, alongside key financial statistics, stock price performance, and analyst consensus recommendations.

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Director Mark V. Anquillare gets 37,425 RSUs at Teladoc Health (TDOC)

Teladoc Health director Mark V. Anquillare was granted 37,425 Restricted Stock Units (RSUs) on August 3, 2026. These RSUs, which represent a contingent right to one share of common stock each, will vest in a staggered manner: one-third on the first anniversary of the …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DOCU - Strip The Tax Benefit And Earnings Grew 36%

This article analyzes DocuSign's (DOCU) financial performance, highlighting that when a non-cash deferred tax valuation allowance benefit is stripped, fiscal 2025 earnings grew by 36%, not declined as reported figures suggest. It emphasizes the importance of Intelligent Agreement Management (IAM) for future growth, as …

DOCU main company
Sharemaestro market context Trend signal active 52 weeks -17.1% DOCU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DocGo Shareholder Alert

Faruqi & Faruqi, LLP is investigating potential claims against DocGo Inc. (NASDAQ: DCGO) and reminds investors who suffered losses between November 8, 2022, and September 17, 2023, of the December 26, 2023, deadline to seek the role of lead plaintiff in a federal securities …

DCGO main company
Sharemaestro market context Price above Trend Line 52 weeks -61.2% DCGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Docebo Announces Participation in Upcoming Investor Conferences in August and September

Docebo Inc. (NASDAQ: DCBO, TSX: DCBO) has announced that its management team will present at several investor and software industry conferences in August and September 2026. These include the Canaccord 46th Annual Growth Conference, Oppenheimer 29th Annual Technology, Internet & Communications Conference, and Citi's …

DCBO main company
Sharemaestro market context Trend signal active 52 weeks -26.0% · Next-week setup negative 43.5% DCBO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc Health (TDOC) On Weaker Earnings And Guidance The Fair Value Debate Returns

Teladoc Health (TDOC) is facing renewed scrutiny after reporting weaker Q2 revenue, a wider net loss, and reduced full-year guidance, leading to a significant stock pullback. Despite a narrative suggesting the stock is 55.5% undervalued with a fair value of $15.00 due to its …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teladoc Health, Inc. Announces Appointment of Mark V. Anquillare to its Board of Directors and on the Board?s Audit & Compensation Committees, Effective August 3, 2026

Teladoc Health, Inc. has announced the appointment of Mark V. Anquillare to its board of directors, effective August 3, 2026. Mr. Anquillare, former president and COO of Verisk Analytics, brings over 30 years of financial and executive leadership experience. He will serve on the …

TDOC main company
Sharemaestro market context Trend signal active 52 weeks -11.3% TDOC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context